Tilray stock price forecast: Downward pressure remains as TLRY gains 4.28% ahead of earnings

Traders Union
All News
Financial News
Tilray rises 4.28% today to $6.95

Highlights

Tilray will report its third fiscal quarter results on April 1, 2026, with a call scheduled pre-market.
Tilray's acquisition of BrewDog is aimed at accelerating its turnaround plan, including a leadership overhaul after BrewDog's craft beer failure.
TLRY trades below major technical levels amid oversold signals, with a forecasted range of $6.80–$7.35 and downside risk prevailing.

BrewDog acquisition and leadership changes shape quarterly earnings anticipation

Tilray has announced it will release its financial results for the third fiscal quarter, which ended on February 28, 2026, before the markets open on April 1, 2026. The company will host a conference call and webcast that morning to discuss the results. Tilray’s recent acquisition of BrewDog comes as the company pursues a turnaround plan involving changes to BrewDog’s leadership following the collapse of its craft beer business.

Bearish momentum persists as oversold signals meet intraday strength

The current price of TLRY at $6.95 remains below the MA-20 ($7.12), MA-50 ($7.75), and MA-200 ($9.50), which signals persistent downward pressure across short-, medium-, and long-term trends. The Ichimoku Kijun at $7.11 stands above the current price, acting as immediate resistance.

Momentum signals are mixed: MACD (D1) and AO are negative, indicating bearish momentum, while ADX is neutral at 12.14, suggesting a weak or uncertain trend. RSI (39.03), CCI (-103.18), and BBP (-0.12) all indicate oversold conditions and sustained seller dominance. Stoch RSI is neutral, but with a value near 78.6, it suggests a recent bounce from oversold territory without clear overbought confirmation. The daily move is upward (up $0.29, or 4.28%), with a mild gap up on the open and current price trading near the upper end of today’s range ($6.77–$7.07). Volatility is moderate, and price action reflects strength toward intraday highs, though this is occurring in the context of conflicting short-term momentum and oscillators.

Downside risk prevails as bearish trend endures despite tight range

For the next five trading days, the expected range is $6.80 to $7.35, keeping movement within roughly ±6% of the current price. The probability of a price increase is very low (less than 20%), with a further decline more likely given that three out of four weekly indicators (RSI, MACD, MA-50, all W1) remain bearish. The baseline scenario is a sideways corridor with resistance at $7.11 and near-term support at $6.80. A bullish scenario would require a break above $7.11, opening the way toward $7.35, while a drop below $6.80 could expose the stock to further weakness.

Viktoras Karapetjanc, expert at Traders Union, sees fundamental improvements on the horizon as Tilray advances its turnaround plan and prepares to release earnings. He notes that the price is still under key moving averages, but recent upward momentum and oversold signals hint at stabilization. Macro and sentiment factors, such as the BrewDog acquisition and leadership changes, could spark renewed interest among investors. Karapetjanc remains constructive, focusing on the potential for a breakout above resistance. "If TLRY can firmly reclaim $7.11, I expect bullish sentiment to strengthen and the stock to approach the $7.35 area in the short term."

Earlier, analysts noted that Tilray faced persistent bearish technical pressure despite diversification and expansion efforts. The current price action, combined with upcoming earnings and recent acquisition developments, keeps the outlook cautious, with traders advised to monitor the $7.11 resistance level for any potential shift in momentum.

Source of Data: TLRY Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.